Abstract:Small molecules that can induce protein degradation by inducing proximity between a desired target and an E3 ligase have the potential to greatly expand the number of proteins that can be manipulated pharmacologically. Current strategies for targeted protein degradation are mostly limited in their target scope to proteins with preexisting ligands. Alternate modalities such as molecular glues, as exemplified by the glutarimide class of ligands for the CUL4CRBN ligase, have been mostly discovered serendipitously. We recently reported a trans-labelling covalent glue mechanism which we named 'Template-assisted covalent modification', where an electrophile decorated small molecule binder of BRD4 was effectively delivered to a cysteine residue on an E3 ligase DCAF16 as a consequence of a BRD4-DCAF16 protein-protein interaction. Herein, we report our medicinal chemistry efforts to evaluate how various electrophilic modifications to the BRD4 binder, JQ1, affect DCAF16 trans-labeling and subsequent BRD4 degradation efficiency. We discovered a decent correlation between the ability of the electrophilic small molecule to induce ternary complex formation between BRD4 and DCAF16 with its ability to induce BRD4 degradation. Moreover, we show that a more solvent-exposed warhead presentation is optimal for DCAF16 recruitment and subsequent BRD4 degradation. Unlike the sensitivity of CUL4CRBN glue degraders to chemical modifications, the diversity of covalent attachments in this class of BRD4 glue degraders suggests a high tolerance and tunability for the BRD4-DCAF16 interaction. This offers a potential new avenue for a rational design of covalent glue degraders by introducing covalent warheads to known binders.

Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders

DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders

Exploration of the Tunability of BRD4 Degradation by DCAF16 Trans-labelling Covalent Glues

Advances in molecular glues: exploring chemical space and design principles for targeted protein degradation

Discovery of CRBN-dependent WEE1 Molecular Glue Degraders from a Multicomponent Combinatorial Library

The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K

Targeted protein degradation via intramolecular bivalent glues

Rational Design of Molecular Glues: Breakthroughs and Perspectives

Discovery of electrophilic degraders that exploit SNAr chemistry

Discovery of Monovalent Direct Degraders of BRD4 That Act Via the Recruitment of DCAF11

Discovery and resistance mechanism of a selective CDK12 degrader

Charged Molecular Glue Discovery Enabled by Targeted Degron Display

Development of potent and selective CK1α Molecular Glue Degraders

Dual-site molecular glues for enhancing protein-protein interactions of the CDK12-DDB1 complex

Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitors

Targeted Protein Degradation: Current and Emerging Approaches for E3 Ligase Deconvolution

A Degron Blocking Strategy Towards Improved CRL4CRBN Recruiting PROTAC Selectivity

Mechanism of degrader-targeted protein ubiquitinability

The cyclimids: Degron-inspired cereblon binders for targeted protein degradation

Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy